Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre's Covaxin price
Hyderabad-based vaccine maker Bharat Biotech on Tuesday said the current supply price of its Covid-19 vaccine Covaxin to the Centre is not sustainable in the long run.